Manufacturer
104 recalls in our database name Wells Pharmacy Network, LLC as the manufacturing or recalling firm.
Of the 104 recalls from Wells Pharmacy Network, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 93 (89%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Wells Pharmacy Network LLC is recalling 16 vials of Dexamethasone Sodium Phosphate 24 mg/mL injectable due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling QUAD1 injectable vials because the FDA determined there is a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP Injectable Kits nationwide because the agency cannot assure the product is sterile.
Wells Pharmacy Network LLC is recalling 1,753 kits of compounded Chorionic Gonadotropin injectable kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 21 vials of Testosterone Cypionate in Sesame Oil Injectable due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 648 vials of MIC/Chromium/B12(M) Injectable because the agency cannot assure the product is sterile.
Wells Pharmacy Network LLC is recalling 325 vials of Ultra-Test Injectable due to a lack of assurance of sterility. The product was distributed nationwide.
Wells Pharmacy Network LLC is recalling 984 vials of MIC/B-Complex Injectable because the product lacks assurance of sterility.
Wells Pharmacy Network LLC is recalling 5,277 kits of compounded Chorionic Gonadotropin injectable kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 41 syringes of Mitomycin Solution Injectable because the agency could not ensure the product was sterile.
Wells Pharmacy is recalling 330 Sermorelin Acetate 28 mg Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Tri 1 (PAP/PHEN/ATROPINE) NR Injectable vials because the product lacks assurance of sterility.
Wells Pharmacy Network LLC is recalling 550 vials of Tri-Test 200 Injectable because there is a lack of assurance of sterility. The product was distributed nationwide.
Wells Pharmacy Network LLC is recalling QUAD4 injectable vials because the FDA determined there is a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 22 vials of a compounded injectable drug due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 908 compounded Chorionic Gonadotropin Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 2,339 compounded Chorionic Gonadotropin Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling MIC Combo injectable vials because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling 1,716 vials of a compounded injectable product nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling compounded Chorionic Gonadotropin injectable kits due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling B-complex + Vit C injectable vials due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 526 vials of compounded Nandrolone Decanoate injectable nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network is recalling Testosterone 60 mg/Anastrazole 4 mg Pellets because they were found to be superpotent or subpotent.
Wells Pharmacy Network is recalling Testosterone 200 mg/Anastrazole 20mg Pellets because they may be superpotent or subpotent.
Wells Pharmacy Network is recalling compounded Testosterone 200 mg/Anastrozole 9 mg Pellets because they are superpotent or subpotent.